ABBVIE INC (1ABBV.MI) Fundamental Analysis & Valuation

BIT:1ABBV • US00287Y1091

Current stock price

171.85 EUR
-8 (-4.45%)
Last:

This 1ABBV.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1ABBV.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ABBV was profitable.
  • 1ABBV had a positive operating cash flow in the past year.
  • In the past 5 years 1ABBV has always been profitable.
  • Each year in the past 5 years 1ABBV had a positive operating cash flow.
1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCF1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • With a decent Return On Assets value of 3.12%, 1ABBV is doing good in the industry, outperforming 69.05% of the companies in the same industry.
  • 1ABBV has a better Return On Invested Capital (14.42%) than 86.90% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is in line with the industry average of 12.00%.
  • The last Return On Invested Capital (14.42%) for 1ABBV is above the 3 year average (12.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1ABBV.MI Yearly ROA, ROE, ROIC1ABBV.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • With a decent Profit Margin value of 6.84%, 1ABBV is doing good in the industry, outperforming 69.05% of the companies in the same industry.
  • 1ABBV's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1ABBV (34.23%) is better than 85.71% of its industry peers.
  • In the last couple of years the Operating Margin of 1ABBV has grown nicely.
  • 1ABBV's Gross Margin of 71.62% is fine compared to the rest of the industry. 1ABBV outperforms 60.71% of its industry peers.
  • 1ABBV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
1ABBV.MI Yearly Profit, Operating, Gross Margins1ABBV.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. 1ABBV.MI Health Analysis

2.1 Basic Checks

  • 1ABBV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for 1ABBV remains at a similar level compared to 1 year ago.
  • 1ABBV has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1ABBV has a worse debt to assets ratio.
1ABBV.MI Yearly Shares Outstanding1ABBV.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
1ABBV.MI Yearly Total Debt VS Total Assets1ABBV.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • 1ABBV has an Altman-Z score of 2.33. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.33, 1ABBV is in line with its industry, outperforming 53.57% of the companies in the same industry.
  • The Debt to FCF ratio of 1ABBV is 3.79, which is a good value as it means it would take 1ABBV, 3.79 years of fcf income to pay off all of its debts.
  • 1ABBV has a Debt to FCF ratio of 3.79. This is in the better half of the industry: 1ABBV outperforms 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.33
ROIC/WACC1.68
WACC8.58%
1ABBV.MI Yearly LT Debt VS Equity VS FCF1ABBV.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • 1ABBV has a Current Ratio of 0.67. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1ABBV's Current ratio of 0.67 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 84.52% of its industry peers.
  • 1ABBV has a Quick Ratio of 0.67. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1ABBV has a worse Quick ratio (0.56) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
1ABBV.MI Yearly Current Assets VS Current Liabilites1ABBV.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. 1ABBV.MI Growth Analysis

3.1 Past

  • The earnings per share for 1ABBV have decreased by -1.19% in the last year.
  • 1ABBV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
  • Looking at the last year, 1ABBV shows a quite strong growth in Revenue. The Revenue has grown by 8.57% in the last year.
  • The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
  • Based on estimates for the next years, 1ABBV will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1ABBV.MI Yearly Revenue VS Estimates1ABBV.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
1ABBV.MI Yearly EPS VS Estimates1ABBV.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

7

4. 1ABBV.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1ABBV is valuated rather expensively with a Price/Earnings ratio of 20.27.
  • 1ABBV's Price/Earnings ratio is a bit cheaper when compared to the industry. 1ABBV is cheaper than 77.38% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of 1ABBV to the average of the S&P500 Index (27.42), we can say 1ABBV is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 13.67, 1ABBV is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 88.10% of the companies listed in the same industry.
  • 1ABBV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.24.
Industry RankSector Rank
PE 20.27
Fwd PE 13.67
1ABBV.MI Price Earnings VS Forward Price Earnings1ABBV.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 76.19% of the companies in the same industry are more expensive than 1ABBV, based on the Enterprise Value to EBITDA ratio.
  • 1ABBV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.13
EV/EBITDA 15.02
1ABBV.MI Per share data1ABBV.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • 1ABBV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of 1ABBV may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ABBV's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%

6

5. 1ABBV.MI Dividend Analysis

5.1 Amount

  • 1ABBV has a Yearly Dividend Yield of 3.31%.
  • 1ABBV's Dividend Yield is rather good when compared to the industry average which is at 0.63. 1ABBV pays more dividend than 96.43% of the companies in the same industry.
  • 1ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.31%

5.2 History

  • The dividend of 1ABBV is nicely growing with an annual growth rate of 6.76%!
Dividend Growth(5Y)6.76%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 278.48% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
  • The dividend of 1ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
1ABBV.MI Yearly Income VS Free CF VS Dividend1ABBV.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
1ABBV.MI Dividend Payout.1ABBV.MI Dividend Payout, showing the Payout Ratio.1ABBV.MI Dividend Payout.PayoutRetained Earnings

1ABBV.MI Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

BIT:1ABBV (4/23/2026, 7:00:00 PM)

171.85

-8 (-4.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners76.21%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap303.96B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target228.25 (32.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.31%
Yearly Dividend5.59
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)6.33%
PT rev (3m)6.21%
EPS NQ rev (1m)-12.35%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)2.12%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)-1.73%
Revenue NQ rev (3m)-1.35%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 20.27
Fwd PE 13.67
P/S 5.86
P/FCF 20.13
P/OCF 18.84
P/B N/A
P/tB N/A
EV/EBITDA 15.02
EPS(TTM)8.48
EY4.93%
EPS(NY)12.57
Fwd EY7.31%
FCF(TTM)8.54
FCFY4.97%
OCF(TTM)9.12
OCFY5.31%
SpS29.31
BVpS-1.57
TBVpS-43.88
PEG (NY)0.42
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.33
F-Score8
WACC8.58%
ROIC/WACC1.68
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / 1ABBV.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.


What is the valuation status for 1ABBV stock?

ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Undervalued.


How profitable is ABBVIE INC (1ABBV.MI) stock?

ABBVIE INC (1ABBV.MI) has a profitability rating of 7 / 10.


What is the financial health of ABBVIE INC (1ABBV.MI) stock?

The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.


What is the expected EPS growth for ABBVIE INC (1ABBV.MI) stock?

The Earnings per Share (EPS) of ABBVIE INC (1ABBV.MI) is expected to grow by 48.29% in the next year.